EW
Edwards Lifesciences Corporation · Healthcare · Medical - Devices
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 165 | -6 | 426.85M | $38.52B | +2 | −7 |
| Q1 2026 | 173 | +2 | 408.99M | $32.75B | +6 | −5 |
| Q4 2025 | 170 | 0 | 441.50M | $37.63B | +2 | −1 |
| Q3 2025 | 24 | -1 | 280.60M | $21.82B | +1 | −3 |
| Q2 2025 | 23 | 0 | 232.09M | $18.15B | — | — |
| Q1 2025 | 20 | -1 | 112.98M | $8.18B | — | −1 |
| Q4 2024 | 21 | +1 | 116.40M | $8.61B | +1 | — |
| Q3 2024 | 19 | +1 | 77.58M | $5.12B | +2 | −1 |
| Q2 2024 | 18 | — | 60.09M | $5.55B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 16.92M | — | $1.56B | 0.3% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 16.92M | — | $1.56B | 0.3% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 16.92M | — | $1.56B | 0.3% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 16.92M | — | $1.56B | 0.3% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 16.92M | — | $1.56B | 0.3% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 16.92M | — | $1.56B | 0.3% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 16.92M | — | $1.56B | 0.3% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 16.92M | — | $1.56B | 0.3% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 16.92M | — | $1.56B | 0.3% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 13.24M | — | $1.22B | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passief) | 13.24M | — | $1.22B | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Norges Bank ✦ (passief) | 8.54M | — | $788.63M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 8.27M | — | $764.05M | 0.3% | n/c | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 7.34M | — | $677.60M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 7.34M | — | $677.60M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | PRIMECAP Management ✦ | 1.81M | — | $167.28M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 649.66K | — | $60.01M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 624.40K | — | $57.68M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 624.40K | — | $57.68M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Millennium Management ✦ | 524.21K | — | $48.42M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 519.81K | — | $48.02M | 0.3% | n/c | 1 | SEC ↗ |
| 22 | Point72 Asset Management ✦ | 444.16K | — | $41.03M | 0.1% | n/c | 1 | SEC ↗ |
| 23 | Baillie Gifford ✦ | 352.30K | — | $32.54M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Baillie Gifford ✦ | 352.30K | — | $32.54M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Baillie Gifford ✦ | 352.30K | — | $32.54M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Baillie Gifford ✦ | 352.30K | — | $32.54M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 309.12K | — | $28.55M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 309.12K | — | $28.55M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 309.12K | — | $28.55M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 309.12K | — | $28.55M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Arrowstreet Capital ✦ | 225.02K | — | $20.79M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Two Sigma Investments ✦ | 152.01K | — | $14.04M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 89.65K | — | $8.28M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | D. E. Shaw & Co. ✦ | 89.65K | — | $8.28M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Marshall Wace ✦ | 74.67K | — | $6.90M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Gotham Asset Management ✦ | 11.86K | — | $1.10M | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 4 houders, 229.24K aandelen, $319,498 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 619 aand · $56,967
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie